Results 21 to 30 of about 54,964 (304)
Patients on P2Y12 inhibitors may still develop thrombosis or bleeding complications. Tailored antiplatelet therapy, based on platelet reactivity testing, might reduce these complications.
Tesse C. Leunissen +11 more
doaj +1 more source
Platelet Activation and Aggregation Induced by Streptococcus bovis/Streptococcus equinus Complex
Streptococcus bovis/Streptococcus equinus complex (SBSEC) is a common cause of infective endocarditis (IE). For IE-pathogens, the capacity to activate and aggregate platelets is believed to be an important virulence mechanism.
Gustav Pernow +4 more
doaj +1 more source
Aggregation of human platelets by Tannerella Forsythia
Context: Periodontitis is a persistent infection of the tissues surrounding the teeth characterized by inflamed microvasculature, and is associated with increased systemic platelet activation.
Eugene J Whitaker +2 more
doaj +1 more source
Investigating small-molecule inhibitors of platelet aggregation [PDF]
Cardiovascular disease, including myocardial infarction, remains the number one cause of worldwide morbidity and mortality. The major cause of myocardial infarction is arterial thrombosis, driven by platelet aggregation.
core +2 more sources
Gloydius venom is a rich natural source of proteins possessing platelet aggregation inhibition activity. These proteins or their recombinant analogs are universal instruments for the investigation of proteins and receptors interaction in hemostatic ...
A. I. Zhukova, G. L. Volkov
doaj +1 more source
Coffee is rich in caffeine (CF), chlorogenic acid (CGA) and phenolics. Differing types of coffee beverages and brewing procedures may result in differences in total phenolic contents (TPC) and biological activities. Inflammation and increases of platelet
Nuntouchaporn Hutachok +6 more
doaj +1 more source
Drug interactions and hepatotoxicity of clopidogrel [PDF]
Clopidogrel (Plavix¨) is an antiplatelet drug, which is clinically used in combination with aspirin to reduce cardiovascular events in patients undergoing percutaneous coronary intervention or in patients suffering from acute coronary syndromes ...
Zahno, Anja-Christina
core +1 more source
Platelet Glycoprotein IIb/IIIa Inhibitors Effects Beyond the Platelet [PDF]
Adjunctive blockade of platelet glycoprotein (GP) IIb/IIIa during percutaneous coronary intervention (PCI) or in patients who present with acute coronary syndromes has been effective in reducing platelet-mediated adverse ischemic clinical outcomes (1–6).
Kereiakes, Dean J +1 more
core +3 more sources
Metabolic plasticity in resting and thrombin activated platelets.
Platelet thrombus formation includes several integrated processes involving aggregation, secretion of granules, release of arachidonic acid and clot retraction, but it is not clear which metabolic fuels are required to support these events.
Saranya Ravi +8 more
doaj +1 more source
The clinical use of Sodium nitroprusside (SNP) may be associated with an alteration of platelet function. The main focus of this study was the effect of SNP on platelet aggregation in the absence or presence of endothelial cells.
Topf Hans-Georg +4 more
doaj +1 more source

